Immunosuppressants

MF: C25H23N3O2 MF: 397.48 CAS: 199119-46-5 Purity: >99%

MF: C5H10N2O4 MF: 162.15 CAS: 687-63-8 Purity: >97%

MF: C15H18N4O4 MF: 318.33 CAS: 20762-31-6 Purity: >99% by TLC

MF: C9H15N3O4 MF: 229.24 CAS: 7561-25-3

á2-Microglobulin, Human Urine, 250UG

á2-Microglobulin, Human Urine, 100UG

Antigen: oligomeric form of A&beta42 Host: mouse Isotype: IgG2b Cross Reactivity: (+) human A&beta unaggregated, oligomeric and fibrillar forms of synthetic A&beta42, and unaggregated A&beta40 (&minus) human APP Application(s): WB, ELISA, ICC,

Antigen: phosphopeptide corresponding to amino acid residues surrounding the phospho-Ser9 of GSK3&beta Host: rabbit Cross Reactivity: (+) rat GSK3&beta expected to react with human, bovine, canine, chicken, mouse, non-human primate, Xenopus, and

Antigen: Peptide from the N-terminal region of human dopamine &beta-hydroxylase (DBH) Host: sheep Cross Reactivity: (+) Human and non-human primate tissue DBH Application: WB

Antigen: Peptide from the C-terminal region of human dopamine &beta-hydroxylase (DBH) Host: sheep Cross Reactivity: (+) Human, mouse, and non-human primate tissue DBH Application: WB

A PKC&alpha and PKC&beta1 inhibitor with IC₅₀ values of 2.3 and 6.2 nM, respectively also inhibits the checkpoint kinases Chk1/2 and abrogates DNA damage-induced cell cycle arrest, leading to cytotoxicity in p53 mutant tumor cells.

Inhibits several isoforms of protein kinase C (PKC IC₅₀ = 7, 7, 6, 10, 60, and 20,000 nM for PKC&alpha, PKC&beta, PKC&gamma, PKC&delta, PKC&zeta, and PKC&mu, respectively) provides cardioprotective effects in myocardial